| P2093 | author name string | M. Gütschow | |
| | C. M González Tanarro | |
| P2860 | cites work | Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition | Q46860364 |
| | First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor. | Q46943887 |
| | A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques. | Q48456115 |
| | The specific velocity plot. A graphical method for determining inhibition parameters for both linear and hyperbolic enzyme inhibitors. | Q52734370 |
| | Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). | Q53210308 |
| | Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease. | Q53283675 |
| | Therapies for Alzheimer's disease. | Q53287138 |
| | Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase | Q79409363 |
| | New Biologically Active N-(Tetrahydrobenzothienopyrimidin-4-YL)-Amino Acids, Thiourethane, Sulfonamides and Related Compounds | Q126242382 |
| | Acetylcholinesterase--new roles for an old actor | Q24291075 |
| | A new and rapid colorimetric determination of acetylcholinesterase activity | Q26778487 |
| | Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs | Q27618667 |
| | Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein | Q28247386 |
| | In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles | Q33525684 |
| | The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design | Q34564655 |
| | Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment | Q34708872 |
| | Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology | Q36134380 |
| | Dimeric and hybrid anti-Alzheimer drug candidates | Q36395551 |
| | One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? | Q36938992 |
| | Amyloid-cholinesterase interactions. Implications for Alzheimer's disease | Q37060531 |
| | Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. | Q37294285 |
| | Tacrine derivatives and Alzheimer's disease. | Q37719563 |
| | Structural insights into substrate traffic and inhibition in acetylcholinesterase | Q41444745 |
| | 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy | Q44457429 |
| | Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates | Q45222504 |
| | Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile | Q46085377 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 350-358 | |
| P577 | publication date | 2010-08-31 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines | |
| P478 | volume | 26 | |